Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial - Concepedia

Concepedia

Publication | Closed Access

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

55

Citations

38

References

2006

Year

Josep‐María Ribera, Juan-José Ortega, Albert Oriol, Pilar Bastida, Carlota Calvo, José-María Pérez-Hurtado, María-Elvira González-Valentín, Victoria Martín-Reina, Antonio Molinés, Fernando Ortega‐Rivas,

Journal of Clinical Oncology

Abstract

This study failed to prove that, when a family donor is available, allogeneic SCT produces a better outcome than autologous SCT or chemotherapy in children with VHR-ALL.

References

	Year	Citations

Page 1